Skip to main content
William Gradishar, MD, Oncology, Chicago, IL

William Gradishar MD

Oncology•Chicago, IL

Breast Cancer, Hematologic Oncology

Betsy Bramsen Professorship of Breast Oncology, Northwestern University Medical School

Join to view full profile

  • 675 N Saint Clair St# GalterChicago, IL 60611

  • Phone+1 312-695-0990

  • Fax+1 312-695-1106

Dr. Gradishar is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Gradishar's full profileAlready have an account?

Education & Training

  • University of Chicago
    University of ChicagoFellowship, Hematology and Medical Oncology, 1986 - 1989
  • Michael Reese Hospital and Medical Center
    Michael Reese Hospital and Medical CenterResidency, Internal Medicine, 1982 - 1986
  • University of Illinois College of Medicine
    University of Illinois College of MedicineClass of 1982

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 1983 - 2029
  • FL State Medical License
    FL State Medical License 2013 - 2015
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification PowerChart, Cerner Corporation, 2011, 2013, 2015-2017
  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2011, 2013, 2015-2017
  • CMS Meaningful Use Stage 1 Certification Northwestern Meaningful Use Data Warehouse Application for Eligible Providers, Northwestern University, 2011, 2013, 2015-2017

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Efficacy of Margetuximab vs Trastuzumab in Patients with Pretreated ERBB2-Positive Advanced Breast Cancer  
    Denise A Yardley, William J Gradishar, JAMA Oncology
  • From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor Sequencing  
    William J Gradishar, Al B Benson, Massimo Cristofanilli, Allison W Kurian, Value in Health

Lectures

  • Predicting expected absolute chemotherapy treatment benefit in women with early-stage breast cancer using a 12-gene expression assay. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
  • Pros and Cons of Extended Adjuvant Endocrine Therapy 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/1/2018

Other

Authored Content

  • From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor SequencingAugust 2018

Press Mentions

  • FDA’s Oncologic Drugs Advisory Committee Splits Vote on Breast and Prostate Cancer Drugs
    FDA’s Oncologic Drugs Advisory Committee Splits Vote on Breast and Prostate Cancer DrugsMay 1st, 2026
  • NCCN Guidelines Navigator for Breast Cancer Genetic Testing and Treatment Debuts During Breast Cancer Awareness Month
    NCCN Guidelines Navigator for Breast Cancer Genetic Testing and Treatment Debuts During Breast Cancer Awareness MonthOctober 6th, 2025
  • New Chicago Breast Cancer Research Consortium Will Increase Access to Clinical Trials
    New Chicago Breast Cancer Research Consortium Will Increase Access to Clinical TrialsSeptember 4th, 2025

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. William Gradishar, Dr. William Gradishar, MD, Dr. W Gradishar